MIRM β€” MIRUM PHARMACEUTICALS INC

Ownership history in WOLVERINE ASSET MANAGEMENT LLC  Β·  4 quarters on record

AI Ownership Summary

WOLVERINE ASSET MANAGEMENT LLC reported MIRUM PHARMACEUTICALS INC (MIRM) in 4 quarterly 13F filings from 2023 Q3 through 2025 Q3. Peak portfolio weight reached 0.01% in 2023 Q3. The latest visible filing shows MIRM at 0.01% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this MIRM ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was WOLVERINE ASSET MANAGEMENT LLC's position in MIRUM PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q3

MIRM was reported at 0.01% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.01% in 2023 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q3 to 2025 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

MIRM stock page WOLVERINE ASSET MANAGEMENT LLC fund profile WOLVERINE ASSET MANAGEMENT LLC full holdings
How WOLVERINE ASSET MANAGEMENT LLC held MIRM β€” position size vs. price
% of Fund (quarterly)    MIRM price (quarter-end, indexed to 100)
πŸ“‹ Quarterly Holdings History 3 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q3 REDUCED 10,670 -9,130 -46.1% 0.01% $782K 2025-10-28 $70.51
2023 Q4 REDUCED 19,800 -1,100 -5.3% 0.01% $584K 2024-02-01 $26.59
2023 Q3 UNCHANGED 20,900 β€” 0% 0.01% $660K 2023-11-13 $30.49
1 older quarter hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding MIRM

As of 2025 Q4 β€” sorted by position size

Frazier Life Sciences Management, L.P. 3Y 14.42% BOONE CAPITAL MANAGEMENT LLC 3Y 10.44% Novo Holdings A/S 3Y 7Y 7.75% Patient Square Capital LP 3Y 5.05% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.82% First Turn Management, LLC 4.35% BVF INC/IL 3Y 7Y 3.98% Highlander Partners, L.P. 3Y 3.49% Rock Springs Capital Management LP 3Y 7Y 3.09% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 2.58%

FAQ About WOLVERINE ASSET MANAGEMENT LLC and MIRM

These are the practical questions this page is built to answer before you even open the full history table.

How long has WOLVERINE ASSET MANAGEMENT LLC reported owning MIRM?

WOLVERINE ASSET MANAGEMENT LLC reported MIRM across 3 quarterly 13F filings, from 2023 Q3 through 2025 Q3.

What was the largest reported MIRM position in WOLVERINE ASSET MANAGEMENT LLC's portfolio?

The largest reported portfolio weight for MIRM was 0.01% in 2023 Q3.

What is the latest reported MIRM position on this page?

The most recent filing on this page is 2025 Q3, when WOLVERINE ASSET MANAGEMENT LLC reported 10,670 shares, equal to 0.01% of portfolio, with an estimated market value of $782K.

What does the chart on this MIRM ownership page compare?

The chart compares WOLVERINE ASSET MANAGEMENT LLC's quarterly MIRM portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to WOLVERINE ASSET MANAGEMENT LLC Holdings